Evaxion A (EVAX) Return on Capital Employed (2021 - 2025)
Evaxion A (EVAX) reported Return on Capital Employed of 37.23% for Q4 2025, up 50.62% quarter-over-quarter from 75.39% in Q2 2025.
Evaxion A (EVAX) Return on Capital Employed (2021 - 2025) Analysis & Trends
Evaxion A has reported Return on Capital Employed for 5 years, with the latest figure at 37.23% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed changed N/A year-over-year to 37.23%; the trailing twelve-month figure through Dec 2025 stood at 37.23% (changed N/A YoY), and the FY2025 full-year result was 57.04%, up 12005.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 37.23%, up from 75.39% in the prior quarter.
- The five-year high for Return on Capital Employed was 37.23% in Q4 2025, with the low at 501.94% in Q2 2024.
- Historically, Return on Capital Employed has averaged 155.2% across 5 years, with a median of 98.25% in 2021.
- Annual changes were most pronounced in 2024 — Return on Capital Employed sank 33167 bps — and 2025, when it soared 42655 bps.
- Evaxion A's Return on Capital Employed stood at 92.87% in 2021, then decreased by 30 bps to 120.47% in 2022, then slumped by 248 bps to 418.79% in 2023, then declined by 20 bps to 501.94% in 2024, then surged by 93 bps to 37.23% in 2025.
- The last three Return on Capital Employed figures came in at 37.23% (Q4 2025), 75.39% (Q2 2025), and 501.94% (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 10.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.23% |
| Jun 30, 2025 | -75.39% |
| Jun 30, 2024 | -501.94% |
| Dec 31, 2023 | -418.79% |
| Jun 30, 2023 | -170.27% |
| Dec 31, 2022 | -120.47% |
| Jun 30, 2022 | -79.34% |
| Mar 31, 2022 | -75.29% |
| Dec 31, 2021 | -92.87% |
| Sep 30, 2021 | -103.64% |
| Jun 30, 2021 | -81.31% |
| Mar 31, 2021 | -105.88% |